-
Product Insights
Neovascular Glaucoma Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Neovascular Glaucoma Global Clinical Trials Review, H1, 2018" provides an overview of Neovascular Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Neovascular Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Graft Versus Host Disease (GVHD): Competitive Landscape to 2026
Hematopoietic stem cell transplantation (HSCT) is the transplantation of autologous or allogeneic stem cells, and is used for the treatment of patients with hematologic disorders, which vary from malignant diseases to genetic anemias. Despite matching or minimally mismatching donors, there are minor histocompatibility antigens that might not match (or for other reasons), triggering the donor’s immune system to attack the recipient, causing the inflammatory disease unique to allogeneic HSCT known as graft versus host disease (GVHD). This report provides an...
-
Sector Analysis
Competitor Landscape: Graft Versus Host Disease (GVHD)
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the graft versus host disease (GVHD) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher